Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoproliferative Disorders × Pemetrexed × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 90 Lung Neoplasms 34 Neoplasms 9 Neoplasm Metastasis 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Mesothelioma, Malignant 7 Colorectal Neoplasms 7 Carcinoma 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Mesothelioma 3 Colonic Neoplasms 3 Advanced Solid Tumors 3 Adenocarcinoma 3 Thoracic Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Ovarian Neoplasms 2 Non-Squamous Non-small Cell Lung Cancer 2 Neoplasms by Site 2 NSCLC 2 Meningeal Carcinomatosis 2 Lung Diseases 2 Carcinoma, Pancreatic Ductal 2 Carcinoma, Bronchogenic 2 Brain Neoplasms 2 Adenocarcinoma of Lung 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

fludarabine 4 Cyclophosphamide 4 fludarabine phosphate 3 Tacrolimus 3 Mycophenolic Acid 3 Busulfan 3 venetoclax 2 Whole-Body Irradiation 2 Rituximab 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mesna 2 Melphalan 2 Bortezomib 2 trametinib 1 liposomal doxorubicin 1 isatuximab 1 dabrafenib 1 Zidovudine 1 Vincristine 1 Valganciclovir 1 Thiotepa 1 Specimen Handling 1 Sirolimus 1 Prednisone 1 Nivolumab 1 Lenalidomide 1 Interferon-alpha 1 Granulocyte Colony-Stimulating Factor 1 Genetic Testing 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡